Paraneoplastic acral vascular syndrome in a patient with metastatic melanoma under immune checkpoint blockade

BMC Cancer

Volumn 17, Issue 1, 2017, Pages

  Gambichler, Thilo ^a   Strutzmann, Stefanie ^a   Tannapfel, Andrea ^a   Susok, Laura ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Digital ischemia; Gangrene; Immune checkpoint blockade; Ipilimumab; Melanoma; Nivolumab

Indexed keywords

ANALGESIC AGENT; IPILIMUMAB; LACTATE DEHYDROGENASE; NIVOLUMAB; PREDNISOLONE; PROSTACYCLIN; PROTEIN S100B; IMMUNOLOGICAL ANTINEOPLASTIC AGENT; MONOCLONAL ANTIBODY;

ADULT; ARTICLE; CANCER STAGING; CASE REPORT; CAUCASIAN; COMPUTER ASSISTED TOMOGRAPHY; DEATH; DIGITAL SUBTRACTION ANGIOGRAPHY; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; ERYTHEMA; FINGER AMPUTATION; FINGER PHALANX; GANGRENE; HAND DISEASE; HAND PAIN; HAND PARESTHESIA; HEAT INTOLERANCE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFLAMMATORY INFILTRATE; INJECTION SITE PAIN; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; MALE; METASTATIC MELANOMA; MIDDLE AGED; MULTIPLE CYCLE TREATMENT; MULTIPLE ORGAN FAILURE; PAIN; PARANEOPLASTIC ACRAL VASCULAR SYNDROME; PARANEOPLASTIC SYNDROME; PATHOGENESIS; RETROPERITONEAL CANCER; SKIN METASTASIS; SUBUNGUAL NECROSIS; TREATMENT DURATION; TREATMENT REFUSAL; VASCULAR DISEASE; FINGER; ISCHEMIA; LIVER TUMOR; LUNG TUMOR; LYMPH NODE; MELANOMA; MORTALITY; PATHOLOGY; RETROPERITONEAL TUMOR; SECONDARY; VASCULARIZATION;

ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS, IMMUNOLOGICAL; FINGERS; HUMANS; IPILIMUMAB; ISCHEMIA; LIVER NEOPLASMS; LUNG NEOPLASMS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; PARANEOPLASTIC SYNDROMES; RETROPERITONEAL NEOPLASMS;

EID: 85018882695     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/s12885-017-3313-6     Document Type: Article

References (14)

1. Poszepczynska-Guigné E, Viguier M, Chosidow O, et al. Paraneoplastic acral vascular syndrome: epidemiologic features, clinical manifestations, and disease sequelae. J Am Acad Dermatol. 2002;47:47-52.
2. Hsu ST, Lee YY, Lie MF. Symmetrical peripheral gangrene of sudden onset - a paraneoplastic syndrome? - a case report and review of the literature. Dematol Sinica. 1996;14:82-8.
3. Hawley PR, Johnston AW, Rankin JT. Association between digital ischaemia and malignant disease. Br Med J. 1967;3:208-12. 15
4. Allen D, Robinson D, Mittoo S. Paraneoplastic Raynaud's phenomenon in a breast cancer survivor. Rheumatol Int. 2010;30:789-92.
5. DeCross AJ, Sahasrabudhe DM. Paraneoplastic Raynaud's phenomenon. Am J Med. 1992;92:571-2.
6. Taylor LM Jr, Hauty MG, Edwards JM, et al. Digital ischemia as a manifestation of malignancy. Ann Surg. 1987;206:62-8.
7. Rodríguez Martín AM, Guirao Arrabal E, Jiménez Puya R, Vélez García-Nieto A. Paraneoplastic Acral Vascular Syndrome. Actas Dermosifiliogr. 2015 Sep;106(7):601-2.
8. Le Besnerais M, Miranda S, Cailleux N, Girszyn N, Marie I, Lévesque H, Benhamou Y. Digital ischemia associated with cancer: results from a cohort study. Medicine (Baltimore). 2014;93(10):e47.
9. Abdel-Wahab N, Shah M, Suarez-Almazor ME. Adverse events associated with immune checkpoint blockade in patients with cancer: a systematic review of case reports. PLoS One. 2016;11(7):e0160221.
10. Michot JM, Bigenwald C, Champiat S, Collins M, Carbonnel F, Postel-Vinay S, Berdelou A, Varga A, Bahleda R, Hollebecque A, Massard C, Fuerea A, Ribrag V, Gazzah A, Armand JP, Amellal N, Angevin E, Noel N, Boutros C, Mateus C, Robert C, Soria JC, Marabelle A, Lambotte O. Immune-related adverse events with immune checkpoint blockade: a comprehensive review. Eur J Cancer. 2016;54:139-48.
11. Wigley FM, Flavahan NA. Raynaud's phenomenon. N Engl J Med. 2016;375(6):556-65.
12. Al-Zahrani H, Gupta V, Minden MD, Messner HA, Lipton JH. Vascular events associated with alpha interferon therapy. Leuk Lymphoma. 2003;44(3):471-5.
13. Dvorak HF, Gresser I. Microvascular injury in pathogenesis of interferon-induced necrosis of subcutaneous tumors in mice. J Natl Cancer Inst. 1989;81(7):497-502.
14. Yshii LM, Gebauer CM, Pignolet B, Mauré E, Quériault C, Pierau M, Saito H, Suzuki N, Brunner-Weinzierl M, Bauer J, Liblau R. CTLA4 blockade elicits paraneoplastic neurological disease in a mouse model. Brain. 2016. [Epub ahead of print] PubMed PMID: 27604307.